Oakley Capital, a pan-European middle-market private equity investor, has announced that Oakley Capital Origin Fund I has acquired a majority stake in Horizons Optical, a provider of medical software used to manufacture premium ophthalmic lenses.
Oakley Capital, a pan-European middle-market private equity investor, has announced that Oakley Capital Origin Fund I has acquired a majority stake in Horizons Optical, a provider of medical software used to manufacture premium ophthalmic lenses.